Home » Topics » Regulatory » Patents

Patents
RSS

MMP inhibitors described by Agouron

Aug. 13, 1997

Bayer reports LTB4 synthesis inhibitors for asthma

Aug. 12, 1997

MMP/TNF-alpha inhibitors from Novartis

Aug. 12, 1997

Orally active PDE IV inhibitors from Merck Frosst

Aug. 11, 1997

Oral carbapenem antibacterial agents from Lederle (Japan)

Aug. 11, 1997

Cephalon reports cysteine/serine protease inhibitors with broad therapeutic potential

Aug. 11, 1997

Tacrine analogs reported for Alzheimer's disease

Aug. 8, 1997

Protein kinase C inhibitors discovered at Cephalon

Aug. 8, 1997

SKB reports new agents for atherosclerosis

Aug. 8, 1997

Atypical beta-adrenoceptor agonists from Glaxo Wellcome

Aug. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...